EMT inhibitor-2 |
Catalog No.GC35981 |
L'inhibiteur EMT-2 (composé 1) inhibe la transition épithéliale-mésenchymateuse (EMT) induite par des substances telles que l'IL-1β et le TGF-β libérées par les immunocytes.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2232228-60-1
Sample solution is provided at 25 µL, 10mM.
EMT inhibitor-2 (Compound 1) inhibits epithelial-mesenchymal transition (EMT) induced by substances such as IL-1β and TGF-β released from the immunocytes. EMT inhibitor-2 inhibits CYP3A4 testosteron and CYP2C9 with IC50s of 49.72 and 5.54 μM, respectively[1].
[1]. Youn, Byung Soo, et al. Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis. US10370364.
Average Rating: 5
(Based on Reviews and 10 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *